Literature DB >> 12883649

Malignant melanoma associates with deficient IFN-induced STAT 1 phosphorylation.

Jan Kovarik1, V Boudny, I Kocak, L Lauerova, V Fait, M Vagundova.   

Abstract

STAT 1, a member of signal transducers and transcription activators of STAT family proteins, has been implicated as important mediator of IFN signaling. Functional activation of STAT 1 requires tyrosine and serine phosphorylation. Defects in its expression or activation in response to IFNs were observed in numerous pathological conditions including cancer. To further explore cancer-associated impaired STAT 1 response to IFNs, the inducibility of serine (S 727) and tyrosine (Y 701) phosphorylation by IFN-alpha/-gamma was assessed in 21 melanoma cell lines and in 35 primary cultures derived from melanoma patients. STAT 1 levels and inducibility of its activated phospho-forms were detected by Western analysis using specific polyclonal and monoclonal antibodies. All cell lines as well as patient melanoma samples expressed STAT 1 with variable signal intensity. Significant impaired IFN-induced STAT 1 S 727 phosphorylation was observed in both model systems with average of 77% of non-responders recorded in patient melanoma cells and 76% in melanoma cell lines. Failure of PY 701 induction occurred in patient samples (63% after IFN-alpha and 34% after IFN-gamma induction) and to a lesser degree in cell lines (i.e. response absence to IFN-alpha in 5 and to IFN-gamma in 2 melanoma lines). Our study demonstrates STAT 1 functional abnormalities in melanoma cells. On the basis of detailed analyses of patient melanoma cells with respect to the inducibility of STAT 1 phosphorylation by IFNs, four categories of patients could be distinguished: a) activation on both S 727 and Y 701, b) not inducible response, c) activation on Y 701 but not on S 727, d) heterogeneous response. Clinical study is now in progress to establish the significance of in vitro STAT 1 activation for predicting the response to IFN-based therapy and to explore biological consequences in cases responding in vitro to IFN-induced STAT 1 activation on only one of the critical amino acid residues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12883649

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  5 in total

Review 1.  Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathways.

Authors:  Xue Bai; David E Fisher; Keith T Flaherty
Journal:  Nat Rev Clin Oncol       Date:  2019-09       Impact factor: 66.675

2.  Correlation of STAT1 with apoptosis and cell-cycle markers in esophageal squamous cell carcinoma.

Authors:  Ying Zhang; Yaozhong Zhang; Hailong Yun; Raymond Lai; Min Su
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

3.  The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma.

Authors:  Ying Zhang; Ommoleila Molavi; Min Su; Raymond Lai
Journal:  BMC Cancer       Date:  2014-10-29       Impact factor: 4.430

4.  Deficiency in STAT1 Signaling Predisposes Gut Inflammation and Prompts Colorectal Cancer Development.

Authors:  Sonia Leon-Cabrera; Armando Vázquez-Sandoval; Emmanuel Molina-Guzman; Yael Delgado-Ramirez; Norma L Delgado-Buenrostro; Blanca E Callejas; Yolanda I Chirino; Carlos Pérez-Plasencia; Miriam Rodríguez-Sosa; Jonadab E Olguín; Citlaltepetl Salinas; Abhay R Satoskar; Luis I Terrazas
Journal:  Cancers (Basel)       Date:  2018-09-19       Impact factor: 6.639

5.  Development of IFN-gamma resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells.

Authors:  M Fojtova; V Boudny; A Kovarik; L Lauerova; L Adamkova; K Souckova; J Jarkovsky; J Kovarik
Journal:  Br J Cancer       Date:  2007-06-19       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.